4.6 Article

Automated polyvinylidene difluoride hollow fiber liquid-phase microextraction of flunitrazepam in plasma and urine samples for gas chromatography/tandem mass spectrometry

期刊

JOURNAL OF CHROMATOGRAPHY A
卷 1216, 期 12, 页码 2241-2247

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.chroma.2009.01.022

关键词

Polyvinylidene difluoride (PVDF) hollow fiber; Automated hollow fiber liquid-phase microextraction (HF-LPME); Flunitrazepam (FLNZ); Plasma and urine samples; Optimization

资金

  1. Natural Sciences and Engineering Council of Canada
  2. Scientific and technological Foundation of Shenzhen, China [05KJba053]

向作者/读者索取更多资源

A new polyvinylidene difluoride (PVDF) hollow fiber (200 mu m wall thickness, 1.2 mm internal diameter. 0.2 mu m pore size) was compared with two other polypropylene (PP) hollow fibers (200, 300 mu m wall thickness, 1.2 mm internal diameter, 0.2 mu m pore size) in the automated hollow fiber liquid-phase microextraction (HF-LPME) of flunitrazepam (FLNZ) in biological samples. With higher porosity and better solvent compatibility, the PVDF hollow fiber showed advantages with faster extraction efficiency and operational accuracy. Parameters of the CTC autosampler program for HF-LPME in plasma and urine samples were carefully investigated to ensure accuracy and reproducibility. Several parameters influencing the efficiency of HF-LPME of FLNZ in plasma and urine samples were optimized, including type of porous hollow fiber, organic solvent, agitation rate, extraction time, salt concentration, organic modifier, and pH. Under optimal conditions, extraction recoveries of FLNZ in plasma and urine samples were 6.5% and 83.5%, respectively, corresponding to the enrichment factor of 13 in plasma matrix and 167 in urine matrix. Excellent sample clean-up was observed and good linearities (r(2) = 0.9979 for plasma sample and 0.9995 for urine sample) were obtained in the range of 0.1-1000 ng/mL(plasma sample) and 0.01-1000 mg/mL, (urine sample). The limits of detection (S/N=3) were 0.025 ng/mL in plasma matrix and 0.001 ng/mL in urine matrix by gas chromatography/mass spectrometry/mass spectrometry. (c) 2009 Elsevier B.V. All Fights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据